Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Peter Fecci

Concepts (341)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
77
2026
1322
12.610
 Why?
Laser Therapy
20
2026
135
7.860
 Why?
Glioblastoma
34
2026
353
7.510
 Why?
Glioma
20
2025
426
4.280
 Why?
Immunotherapy
30
2025
657
4.150
 Why?
Hyperthermia, Induced
8
2024
121
3.100
 Why?
T-Lymphocytes
16
2024
1982
2.610
 Why?
CD8-Positive T-Lymphocytes
11
2026
917
2.540
 Why?
Radiosurgery
11
2025
401
2.290
 Why?
Radiation Injuries
6
2026
151
2.250
 Why?
Lymphocytes, Tumor-Infiltrating
10
2026
154
2.130
 Why?
Neoplasms
13
2026
2884
1.990
 Why?
Central Nervous System Neoplasms
3
2025
174
1.650
 Why?
Cancer Vaccines
9
2022
160
1.230
 Why?
Tumor Microenvironment
15
2026
735
1.200
 Why?
Gold
3
2024
116
1.010
 Why?
Clinical Trials as Topic
7
2025
1054
0.960
 Why?
Receptors, Tumor Necrosis Factor, Type II
1
2026
41
0.950
 Why?
Lymphocytic Choriomeningitis
1
2026
25
0.940
 Why?
Lasers
6
2025
132
0.930
 Why?
Antigens, Neoplasm
4
2024
272
0.920
 Why?
Radiotherapy
2
2026
206
0.920
 Why?
Humans
105
2026
144957
0.910
 Why?
Integrin alpha4beta1
1
2025
8
0.900
 Why?
Animals
48
2026
38109
0.900
 Why?
Interleukin-7
1
2025
65
0.870
 Why?
Dog Diseases
1
2025
70
0.870
 Why?
B7-H1 Antigen
6
2019
241
0.850
 Why?
Patient Selection
2
2025
719
0.840
 Why?
Immunotherapy, Adoptive
9
2026
337
0.800
 Why?
Antigen Presentation
1
2024
205
0.800
 Why?
CD4-Positive T-Lymphocytes
4
2021
1129
0.780
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
2
2019
23
0.760
 Why?
Mice
30
2026
18365
0.760
 Why?
Cell Line, Tumor
11
2026
3550
0.730
 Why?
Subarachnoid Hemorrhage
2
2022
71
0.720
 Why?
Programmed Cell Death 1 Receptor
3
2019
264
0.710
 Why?
Neoplasm Proteins
1
2025
444
0.710
 Why?
Immunophenotyping
4
2021
322
0.700
 Why?
Pituitary Neoplasms
3
2025
190
0.690
 Why?
Gene Expression Regulation, Neoplastic
4
2025
1462
0.680
 Why?
Urinary Tract Infections
1
2023
203
0.670
 Why?
Hydrocephalus
1
2022
111
0.660
 Why?
Flow Cytometry
6
2020
1173
0.650
 Why?
Surgical Wound Infection
1
2023
316
0.630
 Why?
Pituitary ACTH Hypersecretion
1
2019
12
0.620
 Why?
Immunity, Cellular
2
2020
272
0.620
 Why?
Antibodies, Monoclonal
6
2019
1524
0.600
 Why?
Neoplasm Recurrence, Local
9
2025
1141
0.600
 Why?
Necrosis
6
2026
244
0.580
 Why?
Combined Modality Therapy
6
2022
1268
0.570
 Why?
Healthcare Disparities
1
2025
728
0.550
 Why?
Mice, Inbred C57BL
13
2026
5997
0.540
 Why?
T-Lymphocytes, Regulatory
4
2018
389
0.510
 Why?
Treatment Outcome
17
2025
11695
0.500
 Why?
Bone Marrow
1
2018
306
0.500
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2018
331
0.480
 Why?
Brain
7
2025
2941
0.460
 Why?
Fluorescein
1
2015
24
0.450
 Why?
Disease Management
4
2026
647
0.450
 Why?
Cognitive Dysfunction
1
2021
464
0.450
 Why?
Blood-Brain Barrier
5
2025
155
0.400
 Why?
Magnetic Resonance Imaging
12
2025
3869
0.390
 Why?
Meningeal Neoplasms
2
2024
94
0.390
 Why?
Epilepsy, Temporal Lobe
2
2025
38
0.380
 Why?
Histocompatibility Antigens Class I
2
2025
202
0.380
 Why?
Astrocytes
1
2015
224
0.380
 Why?
Interleukin-2 Receptor alpha Subunit
3
2007
80
0.370
 Why?
Cytokines
6
2020
2065
0.360
 Why?
Disease Models, Animal
7
2026
4569
0.360
 Why?
Medical Oncology
3
2026
332
0.350
 Why?
Dendritic Cells
4
2017
499
0.340
 Why?
Metal Nanoparticles
2
2024
86
0.340
 Why?
Drug Resistant Epilepsy
2
2025
137
0.330
 Why?
Aged
21
2025
25947
0.330
 Why?
Interleukin-12
2
2026
117
0.320
 Why?
Adult
22
2025
40506
0.320
 Why?
Disease Susceptibility
3
2021
348
0.320
 Why?
Carcinoma, Non-Small-Cell Lung
4
2025
1182
0.320
 Why?
Immunity
2
2021
139
0.310
 Why?
Lung Neoplasms
7
2025
2642
0.310
 Why?
Female
32
2025
78376
0.310
 Why?
Middle Aged
24
2025
35928
0.300
 Why?
Aged, 80 and over
7
2025
8279
0.290
 Why?
Neoplasms, Experimental
2
2020
173
0.290
 Why?
Retrospective Studies
12
2025
17101
0.290
 Why?
Survival Rate
5
2020
2092
0.290
 Why?
Phototherapy
2
2019
48
0.280
 Why?
Adenoma
3
2025
218
0.280
 Why?
Melanoma
2
2025
761
0.280
 Why?
Biopsy
5
2025
1077
0.270
 Why?
Prospective Studies
8
2025
7997
0.260
 Why?
Robotic Surgical Procedures
2
2020
182
0.260
 Why?
Ficusin
2
2017
6
0.260
 Why?
Antigens, Differentiation
1
2007
77
0.250
 Why?
Meningioma
2
2025
87
0.240
 Why?
Tumor Escape
2
2019
49
0.240
 Why?
High Mobility Group Proteins
1
2026
45
0.230
 Why?
Quality of Life
4
2025
3192
0.230
 Why?
Toll-Like Receptor 8
1
2025
8
0.230
 Why?
Male
25
2025
72406
0.230
 Why?
Toll-Like Receptor 7
1
2025
43
0.230
 Why?
Supervised Machine Learning
1
2025
23
0.230
 Why?
Stereotaxic Techniques
3
2022
42
0.220
 Why?
Genetic Therapy
2
2008
313
0.220
 Why?
Integrin alpha6
1
2024
9
0.210
 Why?
Dogs
1
2025
438
0.210
 Why?
Imidazoles
1
2025
254
0.210
 Why?
Biomarkers, Tumor
3
2021
1322
0.200
 Why?
Antigens, CD
1
2007
555
0.200
 Why?
Prognosis
3
2024
4293
0.200
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2023
7
0.200
 Why?
T-Lymphocyte Subsets
1
2006
415
0.200
 Why?
Radiotherapy Dosage
1
2024
289
0.200
 Why?
Meninges
1
2024
49
0.200
 Why?
ErbB Receptors
3
2017
629
0.200
 Why?
Mice, Knockout
3
2026
3125
0.200
 Why?
Urinalysis
1
2023
80
0.200
 Why?
Up-Regulation
1
2026
852
0.190
 Why?
Immunohistochemistry
4
2018
1718
0.190
 Why?
Retroviridae
1
2002
101
0.180
 Why?
Positron Emission Tomography Computed Tomography
1
2023
117
0.180
 Why?
Neural Pathways
1
2024
311
0.180
 Why?
Heating
1
2022
18
0.180
 Why?
Adenoviridae
1
2002
199
0.180
 Why?
Xenograft Model Antitumor Assays
1
2025
930
0.180
 Why?
Spine
1
2023
182
0.180
 Why?
Bone Neoplasms
1
2024
256
0.170
 Why?
Herpesvirus 1, Human
1
2002
84
0.170
 Why?
Antigens
1
2023
347
0.170
 Why?
Neurosurgeons
1
2021
17
0.170
 Why?
Interferon-gamma
3
2018
784
0.170
 Why?
Steroids
1
2022
160
0.170
 Why?
Genetic Vectors
1
2002
337
0.170
 Why?
Oncolytic Virotherapy
2
2013
13
0.170
 Why?
Breast Neoplasms
2
2024
2456
0.170
 Why?
Immune Tolerance
3
2021
379
0.160
 Why?
Neoplasm Metastasis
2
2021
695
0.160
 Why?
Interleukin-2
2
2018
437
0.160
 Why?
Dexamethasone
2
2021
372
0.150
 Why?
Perioperative Period
1
2019
71
0.150
 Why?
Genomics
1
2025
836
0.150
 Why?
Mood Disorders
1
2020
140
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2025
988
0.150
 Why?
CTLA-4 Antigen
2
2012
104
0.150
 Why?
Registries
4
2025
2385
0.150
 Why?
Machine Learning
1
2025
587
0.150
 Why?
CD28 Antigens
1
2018
58
0.140
 Why?
Brain Diseases
1
2020
153
0.140
 Why?
T-Lymphocytes, Cytotoxic
1
2019
177
0.140
 Why?
Neurosurgical Procedures
1
2020
202
0.140
 Why?
Cellular Microenvironment
1
2019
94
0.140
 Why?
Lymphopenia
1
2018
65
0.140
 Why?
Sphingosine
1
2018
45
0.140
 Why?
Cerebellar Neoplasms
1
2020
177
0.140
 Why?
Biomarkers
2
2021
4275
0.140
 Why?
Vaccines, Subunit
2
2017
53
0.140
 Why?
Skin Neoplasms
1
2025
847
0.140
 Why?
Lymphoid Tissue
1
2018
80
0.140
 Why?
Lysophospholipids
1
2018
77
0.130
 Why?
Mammary Neoplasms, Animal
1
2017
34
0.130
 Why?
Endocytosis
1
2018
168
0.130
 Why?
Photosensitizing Agents
1
2017
42
0.130
 Why?
RNA-Binding Proteins
1
2021
464
0.130
 Why?
Melanoma, Experimental
1
2017
108
0.130
 Why?
Alzheimer Disease
1
2023
622
0.130
 Why?
Monocytes
1
2020
538
0.130
 Why?
Heart Ventricles
1
2022
760
0.130
 Why?
Leukocytes, Mononuclear
1
2019
573
0.130
 Why?
Major Histocompatibility Complex
1
2017
229
0.130
 Why?
X-Ray Therapy
1
2016
2
0.120
 Why?
Tissue and Organ Procurement
1
2020
346
0.120
 Why?
Macrophages
2
2024
1511
0.120
 Why?
Hyaluronic Acid
1
2018
208
0.120
 Why?
Spleen
1
2018
508
0.120
 Why?
Cognition Disorders
1
2020
538
0.120
 Why?
Neutrophil Infiltration
1
2016
104
0.110
 Why?
Cellular Senescence
1
2018
226
0.110
 Why?
Forkhead Transcription Factors
2
2006
202
0.110
 Why?
Neurosurgery
1
2015
41
0.110
 Why?
Publications
1
2015
48
0.110
 Why?
Immunity, Innate
3
2025
846
0.110
 Why?
Bibliometrics
1
2015
63
0.110
 Why?
Adaptive Immunity
1
2016
169
0.110
 Why?
Blood Coagulation Factors
1
2014
55
0.100
 Why?
Publishing
1
2015
114
0.100
 Why?
Intracranial Hemorrhages
1
2014
100
0.100
 Why?
Young Adult
5
2025
14126
0.100
 Why?
Warfarin
1
2014
170
0.100
 Why?
Simplexvirus
1
2013
82
0.100
 Why?
Tumor Necrosis Factor-alpha
1
2018
1217
0.100
 Why?
Anti-Bacterial Agents
1
2023
1915
0.090
 Why?
Palliative Care
1
2021
1008
0.090
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2012
55
0.090
 Why?
Antidotes
1
2014
145
0.090
 Why?
Models, Immunological
1
2012
100
0.090
 Why?
Antibodies
1
2014
403
0.090
 Why?
Gene Expression
1
2016
1490
0.090
 Why?
Follow-Up Studies
3
2025
5417
0.080
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
161
0.080
 Why?
Hydrogels
1
2018
700
0.080
 Why?
Glycyrrhiza
1
2010
3
0.080
 Why?
Posterior Leukoencephalopathy Syndrome
1
2010
10
0.080
 Why?
Adolescent
5
2025
22453
0.080
 Why?
Tumor Cells, Cultured
1
2012
919
0.080
 Why?
Gene Expression Regulation
1
2019
2609
0.080
 Why?
Cerebrovascular Disorders
1
2010
103
0.080
 Why?
Vasoconstriction
1
2010
217
0.070
 Why?
Tumor Burden
2
2021
322
0.070
 Why?
Brain Injuries
1
2014
508
0.070
 Why?
Research Design
1
2014
1137
0.070
 Why?
Cerebrovascular Circulation
1
2010
280
0.070
 Why?
Incidence
2
2025
2883
0.070
 Why?
Infant
1
2022
10039
0.070
 Why?
Lymphocyte Activation
2
2013
1126
0.060
 Why?
Cell Movement
2
2024
965
0.060
 Why?
Leukocyte Common Antigens
1
2006
88
0.060
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2007
66
0.060
 Why?
Immunomodulation
2
2019
101
0.060
 Why?
CD4 Antigens
1
2006
139
0.060
 Why?
Proprotein Convertase 9
1
2025
87
0.060
 Why?
Multivariate Analysis
2
2019
1540
0.060
 Why?
Th2 Cells
1
2006
171
0.060
 Why?
Bone Marrow Cells
1
2006
320
0.050
 Why?
Cell Survival
2
2018
1098
0.050
 Why?
Mutation
3
2021
4099
0.050
 Why?
Glial Cell Line-Derived Neurotrophic Factor
1
2024
17
0.050
 Why?
Spectrometry, Fluorescence
1
2025
168
0.050
 Why?
Basement Membrane
1
2024
32
0.050
 Why?
SEER Program
1
2025
224
0.050
 Why?
Internship and Residency
1
2015
1257
0.050
 Why?
Neural Cell Adhesion Molecules
1
2024
38
0.050
 Why?
Lymphocytes
1
2006
382
0.050
 Why?
Laminin
1
2024
72
0.050
 Why?
Neoplasm Grading
1
2025
309
0.050
 Why?
Antineoplastic Agents
2
2025
2197
0.050
 Why?
Mice, SCID
1
2024
369
0.050
 Why?
Radiotherapy Planning, Computer-Assisted
1
2024
149
0.050
 Why?
Matrix Metalloproteinase 9
1
2023
132
0.050
 Why?
Calcium-Calmodulin-Dependent Protein Kinase Kinase
1
2022
4
0.050
 Why?
Thymidine Kinase
1
2002
16
0.050
 Why?
Membrane Glycoproteins
1
2025
496
0.050
 Why?
Radioimmunotherapy
1
2002
25
0.050
 Why?
Ganciclovir
1
2002
53
0.050
 Why?
Tomography, Emission-Computed
1
2002
71
0.050
 Why?
Immunization, Passive
1
2002
87
0.050
 Why?
Neoplasm Invasiveness
1
2024
509
0.050
 Why?
History, 21st Century
1
2003
219
0.050
 Why?
Immunologic Memory
2
2019
366
0.050
 Why?
Immunotoxins
1
2002
55
0.050
 Why?
Seizures
2
2020
477
0.050
 Why?
History, 20th Century
1
2003
325
0.040
 Why?
Ablation Techniques
1
2022
36
0.040
 Why?
Antibodies, Bispecific
1
2002
64
0.040
 Why?
Signal Transduction
3
2024
5233
0.040
 Why?
Societies, Medical
1
2026
887
0.040
 Why?
Lymphocyte Count
1
2021
164
0.040
 Why?
Karnofsky Performance Status
1
2020
37
0.040
 Why?
Socioeconomic Factors
1
2025
1327
0.040
 Why?
Cerebellar Diseases
1
2020
27
0.040
 Why?
Image Processing, Computer-Assisted
1
2025
781
0.040
 Why?
Staining and Labeling
1
2020
151
0.040
 Why?
Virus Replication
1
2002
529
0.040
 Why?
Central Nervous System
1
2022
281
0.040
 Why?
Standard of Care
1
2019
80
0.040
 Why?
Cerebellum
1
2020
223
0.040
 Why?
Minimally Invasive Surgical Procedures
1
2020
192
0.040
 Why?
Nanotechnology
1
2019
126
0.040
 Why?
Viscosity
1
2018
90
0.030
 Why?
Heterografts
1
2018
144
0.030
 Why?
Viral Matrix Proteins
1
2017
29
0.030
 Why?
Antineoplastic Agents, Immunological
1
2020
199
0.030
 Why?
Luminescent Measurements
1
2017
76
0.030
 Why?
Adoptive Transfer
1
2017
198
0.030
 Why?
Child
3
2025
22657
0.030
 Why?
Cytomegalovirus
1
2017
168
0.030
 Why?
Antiviral Agents
1
2002
768
0.030
 Why?
Dose-Response Relationship, Radiation
1
2016
140
0.030
 Why?
Killer Cells, Lymphokine-Activated
2
2008
12
0.030
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2016
29
0.030
 Why?
Risk Assessment
1
2025
3676
0.030
 Why?
Receptors, Virus
1
2016
96
0.030
 Why?
Gene Expression Profiling
2
2016
1786
0.030
 Why?
Phosphoproteins
1
2017
346
0.030
 Why?
Intensive Care Units
1
2021
916
0.030
 Why?
Critical Illness
1
2021
892
0.030
 Why?
AMP-Activated Protein Kinases
1
2016
191
0.030
 Why?
International Normalized Ratio
1
2014
49
0.030
 Why?
Multiple Sclerosis
1
2020
484
0.030
 Why?
Cell Transformation, Neoplastic
1
2016
339
0.030
 Why?
Spinal Diseases
1
2014
50
0.030
 Why?
Neurons
1
2022
1642
0.020
 Why?
Tertiary Care Centers
1
2014
189
0.020
 Why?
Feasibility Studies
1
2017
1095
0.020
 Why?
Oncogenes
1
2013
119
0.020
 Why?
Injections, Intraventricular
1
2012
58
0.020
 Why?
Reproducibility of Results
1
2020
3415
0.020
 Why?
Plasma
1
2014
225
0.020
 Why?
Injections, Intraperitoneal
1
2012
117
0.020
 Why?
Gamma Rays
1
2012
56
0.020
 Why?
Neoplasm Transplantation
1
2012
252
0.020
 Why?
Computational Biology
1
2016
681
0.020
 Why?
Molecular Targeted Therapy
1
2014
434
0.020
 Why?
Nimodipine
1
2010
6
0.020
 Why?
Headache Disorders, Primary
1
2010
4
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2013
851
0.020
 Why?
Risk Factors
1
2025
10792
0.020
 Why?
Verapamil
1
2010
37
0.020
 Why?
Blotting, Western
1
2013
1187
0.020
 Why?
Kaplan-Meier Estimate
1
2013
966
0.020
 Why?
Cerebral Angiography
1
2010
119
0.020
 Why?
Hospitalization
1
2020
2434
0.020
 Why?
Neoplastic Stem Cells
1
2013
412
0.020
 Why?
Cohort Studies
1
2019
5965
0.020
 Why?
Anticoagulants
1
2014
724
0.020
 Why?
Hemorrhage
1
2014
809
0.020
 Why?
Vision Disorders
1
2010
178
0.020
 Why?
Vasodilator Agents
1
2010
331
0.020
 Why?
Hydrocortisone
1
2010
304
0.020
 Why?
RNA, Messenger
1
2016
2832
0.020
 Why?
Mice, Transgenic
1
2013
2185
0.020
 Why?
Immunologic Surveillance
1
2008
25
0.020
 Why?
Administration, Oral
1
2010
848
0.020
 Why?
Cell Line
1
2013
2882
0.020
 Why?
Apoptosis
1
2016
2430
0.020
 Why?
Antigen-Presenting Cells
1
2008
160
0.020
 Why?
Randomized Controlled Trials as Topic
1
2014
1721
0.020
 Why?
United States
1
2025
15988
0.020
 Why?
Toll-Like Receptors
1
2008
194
0.020
 Why?
Adjuvants, Immunologic
1
2008
245
0.020
 Why?
Models, Animal
1
2008
392
0.020
 Why?
Practice Guidelines as Topic
1
2014
1563
0.010
 Why?
Amyloid beta-Peptides
1
2008
241
0.010
 Why?
Cell Culture Techniques
1
2008
375
0.010
 Why?
Immunotherapy, Active
1
2003
9
0.010
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
1
2003
28
0.010
 Why?
Hypertension
1
2010
1264
0.010
 Why?
Lymph Nodes
1
2003
502
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2738
0.010
 Why?
Rats
1
2008
5614
0.010
 Why?
Case-Control Studies
1
2006
3608
0.010
 Why?
Fecci's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (341) concept(s)
_
Co-Authors Expand Description
See all (2) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)